Please assess the completion status of the following clinical trial:

Trial Title: Caffeine in Children With Obstructive Sleep Apnea, Dose Response Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Children with OSA and/or increased end tidal C02 (sleep related hypoventilation, obstructive hypoventilation or sustained alveolar hypoventilation), 2-12 years of age, and both genders will be eligible to be part of the study. OSA and its severity will be diagnosed by a preoperative polysomnography.~Exclusion Criteria:~* Children with compromised cardiovascular, pulmonary or renal function, those with congenital syndromes, sickle cell disease, history of seizures and those receiving theophylline will be excluded.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 12 Years
- Healthy Volunteers: t

Study Arms:
- Caffeine and Sodium Benzoate 10 mg/kg IV (Type: EXPERIMENTAL): Group 1 of randomized study.
- Caffeine and Sodium Benzoate 20 mg/kg IV (Type: EXPERIMENTAL): Group 2 of randomized study
- 0.9 NS Saline (Type: PLACEBO_COMPARATOR): Control group of randomized study.

Based on this trial design, predict the completion outcome and termination type (if applicable).